The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?

被引：0
作者：
Naranie Shanmuganathan
Susan Branford
机构：
[1] SA Pathology,Department of Genetics and Molecular Pathology
[2] South Australian Health and Medical Research Institute,Precision Medicine Theme
[3] University of Adelaide,School of Medicine
[4] Royal Adelaide Hospital and SA Pathology,Department of Haematology
[5] University of South Australia,School of Health Sciences
[6] University of South Australia,School of Pharmacy and Medical Science
[7] University of Adelaide,School of Biological Sciences
来源：
Current Hematologic Malignancy Reports | 2019年 / 14卷
关键词：
Next-generation sequencing; Mutations; Disease progression; Resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 506
页数：5
相关论文
共 568 条
[1]  
Valent P(2019)Clonal hematopoiesis with oncogenic potential (CHOP): separation from CHIP and roads to AML Int J Mol Sci. 20 789-162
[2]  
Kern W(2001)Two genetic hits (more or less) to cancer Nature reviews Cancer. 1 157-1464
[3]  
Hoermann G(2003)Chronic myeloid leukemia — advances in biology and new approaches to treatment N Engl J Med 349 1451-884
[4]  
Milosevic Feenstra JD(2013)European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 Blood 122 872-2405
[5]  
Sotlar K(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood. 127 2391-2221
[6]  
Pfeilstöcker M(2016)Genomic classification and prognosis in acute myeloid leukemia N Engl J Med. 374 2209-1004
[7]  
Germing U(2003)Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia New England Journal of Medicine 348 994-2270
[8]  
Sperr WR(2010)Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia N Engl J Med 362 2260-2259
[9]  
Reiter A(2010)Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia N Engl J Med 362 2251-3492
[10]  
Wolf D(2012)Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial Journal of Clinical Oncology 30 3486-927
12345678910